- Replication of sensory anhedonia as a predictor of escitalopram response: evidence from the NeuroPharm study
- Escitalopram and brain reactivity to aggressive stimuli in premenstrual dysphoric disorder
- Neurophysiological Correlates of Neuroanatomical Dimensions in Major Depressive Disorder: Electroencephalographic Markers of Brain Function and Treatment Outcome
- Correction: Amygdala reactivity to threat, negative facial perception, and risk of future psychiatric hospitalizations: a longitudinal study in major depressive and bipolar disorders
- Serotonin and working memory in mood disorder and healthy states: multi-cohort positron emission tomography study
- Age-dependent acceleration of structural brain aging in medication-free major depressive disorder linked to neuroanatomical phenotype findings from COORDINATE-MDD consortium
- Psychological well-being in early pregnancy and pregnancy outcomes: A cohort study
- Hormonal contraceptives and EEG biomarkers for antidepressant treatment response in women
- Brain 5-HT4 receptor, gastrointestinal symptoms, and SSRI-related nausea in depression
- Brain 5-HT4 receptor, gastrointestinal symptoms, and SSRI-related nausea in depression
- Brain 5-HT4 receptor, gastrointestinal symptoms, and SSRI-related nausea in depression
- Amygdala reactivity to threat, negative facial perception, and risk of future psychiatric hospitalizations: a longitudinal study in major depressive and bipolar disorders
- Neuroanatomical dimensions in major depression linked to cognition, adverse life events, self-harm, metabolomics and genetics
- Serotonergic activity estimated by EEG loudness-dependent auditory evoked potentials as a predictor of sexual SSRI side effects
- Corrigendum to “A scoping review of functional genomics in perinatal depression”. [Front. Neuroendocrinol. 78 (2025) 101202]
- Reduced ventromedial prefrontal cortex volume and impaired attention associated with past suicide attempts in patients with mood disorders
- Whole blood BDNF is lower in patients with depression and unchanged by escitalopram in patients and healthy controls
- Associations of serotonin-related brain morphology in early adolescence with behavioral and emotional problems
- Evaluating the association between steroid hormones and filtering of sensory information in healthy women
- Knowledge gaps in psychedelic medicalisation: Preclinical and neuroimaging mechanisms
- Psychoneuroendocrine profiles of unmedicated men with major depressive disorder and associations to treatment effects and sexual side-effects
- No association between serotonin 4 receptor brain binding and personality trait Neuroticism – A positron emission tomography study in depressed patients and healthy individuals
- Low-grade inflammation and serotonin 4 receptor binding in the healthy and the depressed brain
- Sex hormones and serotonin 4 receptor brain binding in men with and without major depressive disorder
- Brain structural correlates of prior alcohol use disorder and their relation to cognitive impairment in individuals with mood disorders
- A scoping review of functional genomics in perinatal depression
- Network-wide aberrancies in neuronal activity during working memory in a large cohort of patients with mood disorders: associations with cognitive impairment and functional disability
- Multivariate associations between structural brain changes and cognitive impairment in partially or fully remitted persons with bipolar disorder
- Methodological obstacles in studies linking hormonal contraception and depression
- Cortisol dynamics and sleep quality: The role of sex and oral contraceptive use
- Effect of combined oral contraceptive use on verbal memory function in healthy women
- Sleep quality in late pregnancy is associated with maternal mental health in the early postpartum period
- Cigarette smoking is associated with levels of the serotonin transporter in the brain: a [11C]DASB PET Study
- Postpartum Hormonal Contraceptive Use and Risk of Depression
- Relation Between Brain Morphological Features and Psychiatric Hospitalization Risk in Major Depressive and Bipolar Disorders
- Postpartum hormonal contraceptive use in Denmark during 1997-2021
- Measuring psychological well-being in a danish pregnancy cohort using the self-reported WHO-5 index
- Disturbing sleep in female adolescent mice does not increase vulnerability to depression triggers later in life
- Women’s perceptions of biological causes and potentials of genomic risk markers in postpartum depression: A qualitative study
- Consistent evidence that brain serotonin 2A receptor binding is positively associated with personality-based risk markers of depression
- Changes in hippocampal volume, 5-HT4 receptor binding, and verbal memory over the course of antidepressant treatment in major depressive disorder
- Changes in hippocampal volume, 5-HT4 receptor binding, and verbal memory over the course of antidepressant treatment in major depressive disorder
- Changes in hippocampal volume, 5-HT4 receptor binding, and verbal memory over the course of antidepressant treatment in major depressive disorder
- Growth Differentiation Factor 15 during pregnancy and postpartum as captured in blood, cerebrospinal fluid and placenta: A cohort study on associations with maternal mental health
- DNA methylation of serotonin genes as predictive biomarkers of antidepressant treatment response
- Whole-brain turbulent dynamics predict responsiveness to pharmacological treatment in major depressive disorder
- Effect of Antidepressant Treatment on 5-HT4 Receptor Binding and Associations With Clinical Outcomes and Verbal Memory in Major Depressive Disorder
- Effect of Antidepressant Treatment on 5-HT4 Receptor Binding and Associations With Clinical Outcomes and Verbal Memory in Major Depressive Disorder
- Effect of Antidepressant Treatment on 5-HT4 Receptor Binding and Associations With Clinical Outcomes and Verbal Memory in Major Depressive Disorder
- Selective serotonin reuptake inhibitors for premenstrual syndrome and premenstrual dysphoric disorder
- Association Between Intrauterine System Hormone Dosage and Depression Risk
- Neuroanatomical dimensions in medication-free individuals with major depressive disorder and treatment response to SSRI antidepressant medications or placebo
- Rumination in patients with major depressive disorder before and after antidepressant treatment
- No association between peripheral serotonin-gene-related DNA methylation and brain serotonin neurotransmission in the healthy and depressed state
- The cortisol awakening response is blunted in healthy women early postpartum
- Serotonin 4 receptor brain binding and oxytocin-promoted affective and social cognition in healthy women – A randomized controlled trial
- EEG abnormalities are not associated with poor antidepressant treatment outcome – A NeuroPharm study
- Postpartum and non-postpartum depression: a population-based matched case-control study comparing polygenic risk scores for severe mental disorders
- Clinical Translation of 5-HT4 Receptor Agonism: A Promising Antidepressant and Procognitive Target
- Clinical Translation of 5-HT4 Receptor Agonism: A Promising Antidepressant and Procognitive Target
- Clinical Translation of 5-HT4 Receptor Agonism: A Promising Antidepressant and Procognitive Target
- Genetic contributions to brain serotonin transporter levels in healthy adults
- Mental Health Symptoms in Oral Contraceptive Users During Short-Term Hormone Withdrawal
- Is serotonin transporter brain binding associated with the cortisol awakening response? An independent non-replication
- Stress Hormone Dynamics Are Coupled to Brain Serotonin 4 Receptor Availability in Unmedicated Patients With Major Depressive Disorder: A NeuroPharm Study
- The association between brain serotonin transporter binding and impulsivity and aggression in healthy individuals
- Sexual health and serotonin 4 receptor brain binding in unmedicated patients with depression-a NeuroPharm study
- Association between brain serotonin 4 receptor binding and reactivity to emotional faces in depressed and healthy individuals
- Depression Associated With Hormonal Contraceptive Use as a Risk Indicator for Postpartum Depression
- Association of neurocognitive function with psychiatric hospitalization and socio-demographic conditions in individuals with bipolar and major depressive disorders
- Deep phenotyping towards precision psychiatry of first-episode depression – the Brain Drugs-Depression cohort
- Association between the loudness dependence of auditory evoked potential, serotonergic neurotransmission and treatment outcome in patients with depression
- Sexual function improves as depressive symptoms decrease during treatment with escitalopram: results of a naturalistic study of patients with major depressive disorder
- Serotonin 4 Receptor Brain Binding in Major Depressive Disorder and Association With Memory Dysfunction
- AI-based dimensional neuroimaging system for characterizing heterogeneity in brain structure and function in major depressive disorder: COORDINATE-MDD consortium design and rationale
- Subacute effects of a single dose of psilocybin on biomarkers of inflammation in healthy humans: An open-label preliminary investigation
- Evaluating cognitive disturbances as treatment target and predictor of antidepressant action in major depressive disorder: A NeuroPharm study
- Reliability of three versus five saliva sampling times for assessing the cortisol awakening response
- Generalizability of treatment outcome prediction in major depressive disorder using structural MRI: A NeuroPharm study
- Postpartum depression: a developed and validated model predicting individual risk in new mothers
- Family History of Psychiatric Disorders as a Risk Factor for Maternal Postpartum Depression: A Systematic Review and Meta-analysis
- Hippocampal volume changes in a pharmacological sex-hormone manipulation risk model for depression in women
- Concurrent anxiety in patients with major depression and cerebral serotonin 4 receptor binding. A NeuroPharm-1 study
- Effects of an Oral Contraceptive on Dynamic Brain States and Network Modularity in a Serial Single-Subject Study
- Short-term oestrogen as a strategy to prevent postpartum depression in high-risk women: protocol for the double-blind, randomised, placebo-controlled MAMA clinical trial
- The role of central serotonergic markers and estradiol changes in perinatal mental health
- Evaluation of the Effect of Supervised Group Exercise on Self-Reported Sleep Quality in Pregnant Women with or at High Risk of Depression: A Secondary Analysis of a Randomized Controlled Trial
- Brain serotonin transporter is associated with cognitive-affective biases in healthy individuals
- Systemic DNA and RNA damage from oxidation after serotonergic treatment of unipolar depression
- Emotional faces processing in major depressive disorder and prediction of antidepressant treatment response: A NeuroPharm study
- Family history of psychiatric disorders as a risk factor for maternal postpartum depression: a systematic review protocol
- The Impact of Hormonal Contraceptive Use on Serotonergic Neurotransmission and Antidepressant Treatment Response: Results From the NeuroPharm 1 Study
- Stress-Hormone Dynamics and Working Memory in Healthy Women Who Use Oral Contraceptives Versus Non-Users
- NeuroPharm study: EEG wakefulness regulation as a biomarker in MDD
- Brain reactivity during aggressive response in women with premenstrual dysphoric disorder treated with a selective progesterone receptor modulator
- Pretreatment qEEG biomarkers for predicting pharmacological treatment outcome in major depressive disorder: Independent validation from the NeuroPharm study
- Default mode network functional connectivity negatively associated with trait openness to experience
- Genome-wide gene expression changes in postpartum depression point towards an altered immune landscape
- Associations between the cortisol awakening response and patient-evaluated stress and mood instability in patients with bipolar disorder: an exploratory study
- Reward processing in major depressive disorder and prediction of treatment response – Neuropharm study
- Oral contraceptives and the serotonin 4 receptor: a molecular brain imaging study in healthy women
- Cognitive processing of infant stimuli in pregnant women with and without affective disorders and the association to postpartum depression
- Effect of supervised group exercise on psychological well-being among pregnant women with or at high risk of depression (the EWE Study): A randomized controlled trial
- Predicting Treatment Outcome in Major Depressive Disorder Using Serotonin 4 Receptor PET Brain Imaging, Functional MRI, Cognitive-, EEG-Based, and Peripheral Biomarkers: A NeuroPharm Open Label Clinical Trial Protocol
- Identification of a Serotonin 2A Receptor Subtype of Schizophrenia Spectrum Disorders With Pimavanserin: The Sub-Sero Proof-of-Concept Trial Protocol
- Pharmacological sex hormone manipulation as a risk model for depression
- Hot and cold cognitive disturbances in antidepressant-free patients with major depressive disorder: a NeuroPharm study
- Psychometric Properties and Validation of the EMOTICOM Test Battery in a Healthy Danish Population
- Different preprocessing strategies lead to different conclusions: A [11C]DASB-PET reproducibility study
- Different preprocessing strategies lead to different conclusions: A [11C]DASB-PET reproducibility study
- Different preprocessing strategies lead to different conclusions: A [11C]DASB-PET reproducibility study
- Optimization of preprocessing strategies in Positron Emission Tomography (PET) neuroimaging: A [11C]DASB PET study
- Optimization of preprocessing strategies in Positron Emission Tomography (PET) neuroimaging: A [11C]DASB PET study
- Optimization of preprocessing strategies in Positron Emission Tomography (PET) neuroimaging: A [11C]DASB PET study
- Genome-wide gene expression in a pharmacological hormonal transition model and its relation to depressive symptoms
- Perinatal Depression: Embracing Variability toward Better Treatment and Outcomes
- Recreational use of psychedelics is associated with elevated personality trait openness: Exploration of associations with brain serotonin markers
- Negative Association Between Allopregnanolone and Cerebral Serotonin Transporter Binding in Healthy Women of Fertile Age
- Trait Openness and serotonin 2A receptors in healthy volunteers: A positron emission tomography study
- Three weeks of SSRI administration enhances the visual perceptual threshold – a randomized placebo-controlled study
- Evidence for oestrogen sensitivity in perinatal depression: pharmacological sex hormone manipulation study
- Neuroticism modulates mood responses to pharmacological sex hormone manipulation in healthy women
- Delirium assessment in neuro-critically ill patients: A validation study
- Seasonality-resilient individuals downregulate their cerebral 5-HT transporter binding in winter – A longitudinal combined 11C-DASB and 11C-SB207145 PET study
- Seasonality-resilient individuals downregulate their cerebral 5-HT transporter binding in winter – A longitudinal combined 11C-DASB and 11C-SB207145 PET study
- Seasonality-resilient individuals downregulate their cerebral 5-HT transporter binding in winter – A longitudinal combined 11C-DASB and 11C-SB207145 PET study
- Paroxetine blunts the corticosterone response to swim-induced stress and increases depressive-like behavior in a rat model of postpartum depression
- Neuroticism Associates with Cerebral in Vivo Serotonin Transporter Binding Differently in Males and Females
- No evidence for a role of the serotonin 4 receptor in five-factor personality traits: A positron emission tomography brain study
- Testosterone levels in healthy men correlate negatively with serotonin 4 receptor binding
- Brain serotonin 4 receptor binding is inversely associated with verbal memory recall
- Pharmacologically Induced Sex Hormone Fluctuation Effects on Resting-State Functional Connectivity in a Risk Model for Depression: A Randomized Trial
- Low frontal serotonin 2A receptor binding is a state marker for schizophrenia?
- Seasonal difference in brain serotonin transporter binding predicts symptom severity in patients with seasonal affective disorder
- Sex hormone manipulation slows reaction time and increases labile mood in healthy women
- Brain serotonin 4 receptor binding is associated with the cortisol awakening response
- Open and Calm–a randomized controlled trial evaluating a public stress reduction program in Denmark
- Evaluation of acute tryptophan depletion and sham depletion with a gelatin-based collagen peptide protein mixture
- Role of emotional processing in depressive responses to sex-hormone manipulation: a pharmacological fMRI study
- Development and psychometric validation of the verbal affective memory test
- Sex-Steroid Hormone Manipulation Reduces Brain Response to Reward
- Preserved consciousness in vegetative and minimal conscious states: systematic review and meta-analysis
- Role of Serotonin Transporter Changes in Depressive Responses to Sex-Steroid Hormone Manipulation: A Positron Emission Tomography Study
- Functional connectivity of the dorsal and median raphe nuclei at rest
- The Center for Integrated Molecular Brain Imaging (Cimbi) database
- Analgesic effect of perioperative escitalopram in high pain catastrophizing patients after total knee arthroplasty: a randomized, double-blind, placebo-controlled trial
- Fluctuations in [¹¹C]SB207145 PET binding associated with change in threat-related amygdala reactivity in humans
- Functional and molecular neuroimaging of menopause and hormone replacement therapy
- Familial risk for major depression is associated with lower striatal 5-HT₄ receptor binding
- The effect of storage conditions on salivary cortisol concentrations using an enzyme immunoassay
- Mental distress and personality in women undergoing GnRH agonist versus GnRH antagonist protocols for assisted reproductive technology
- BDNF Val66met and 5-HTTLPR polymorphisms predict a human in vivo marker for brain serotonin levels
- Effects of selective serotonin reuptake inhibition on neural activity related to risky decisions and monetary rewards in healthy males
- In abstinent MDMA users the cortisol awakening response is off-set but associated with prefrontal serotonin transporter binding as in non-users
- Does Harm Avoidance mediate effects of recollected parental bonding on mental distress in adulthood?
- Central 5-HT4 receptor binding as biomarker of serotonergic tonus in humans: a [11C]SB207145 PET study
- Trait aggression and trait impulsivity are not related to frontal cortex 5-HT2A receptor binding in healthy individuals
- Hypothalamic-pituitary-adrenal axis tonus is associated with hippocampal microstructural asymmetry
- Prefrontal serotonin transporter availability is positively associated with the cortisol awakening response
- Cortisol awakening response and negative emotionality linked to asymmetry in major limbic fibre bundle architecture
- Mindfulness training affects attention–or is it attentional effort?
- In vivo imaging of cerebral serotonin transporter and serotonin(2A) receptor binding in 3,4-methylenedioxymethamphetamine (MDMA or “ecstasy”) and hallucinogen users
- Serotonin transporter binding in the hypothalamus correlates negatively with tonic heat pain ratings in healthy subjects: a [11C]DASB PET study
- Loss of serotonin 2A receptors exceeds loss of serotonergic projections in early Alzheimer’s disease: a combined [11C]DASB and [18F]altanserin-PET study
- Cerebral serotonin transporter binding is inversely related to body mass index
- Endogenous plasma estradiol in healthy men is positively correlated with cerebral cortical serotonin 2A receptor binding
- A nonlinear relationship between cerebral serotonin transporter and 5-HT(2A) receptor binding: an in vivo molecular imaging study in humans
- Coping styles in healthy individuals at risk of affective disorder
- Familial risk for mood disorder and the personality risk factor, neuroticism, interact in their association with frontolimbic serotonin 2A receptor binding
- Gender and the use of hormonal contraception in women are not associated with cerebral cortical 5-HT 2A receptor binding
- Brain serotonin 2A receptor binding: relations to body mass index, tobacco and alcohol use
- A probabilistic approach to delineating functional brain regions
- High familial risk for mood disorder is associated with low dorsolateral prefrontal cortex serotonin transporter binding
- The personality trait openness is related to cerebral 5-HTT levels
- A PET [18F]altanserin study of 5-HT2A receptor binding in the human brain and responses to painful heat stimulation
- Required time delay from 99mTc-HMPAO injection to SPECT data acquisition: healthy subjects and patients with rCBF pattern
- The 5-HT2A receptor binding pattern in the human brain is strongly genetically determined
- Cortical and subcortical 5-HT2A receptor binding in neuroleptic-naive first-episode schizophrenic patients
- Evaluation of the Serotonin Transporter Ligand 123I-ADAM for SPECT Studies on Humans
- Frontolimbic serotonin 2A receptor binding in healthy subjects is associated with personality risk factors for affective disorder
- Reproducibility of 5-HT2A receptor measurements and sample size estimations with [18F]altanserin PET using a bolus/infusion approach
- Autonomic dysfunction and impaired cerebral autoregulation in cirrhosis
- Quantification of 123I-PE2I binding to dopamine transporter with SPECT after bolus and bolus/infusion
- MR-based automatic delineation of volumes of interest in human brain PET images using probability maps
- Renal stone and primary hyperparathyroidism. Risk of renal stone before and after parathyroidectomy
- A database of [(18)F]-altanserin binding to 5-HT(2A) receptors in normal volunteers: normative data and relationship to physiological and demographic variables
- Cardiovascular events before and after surgery for primary hyperparathyroidism
- Risk of renal stone events in primary hyperparathyroidism before and after parathyroid surgery: controlled retrospective follow up study
- Primary hyperparathyroidism: renal calcium excretion in patients with and without renal stone sisease before and after parathyroidectomy
- Cohort study of fracture risk before and after surgery of primary hyperparathyroidism
- Cohort study of risk of fracture before and after surgery for primary hyperparathyroidism